ADVFN ADVFN

Hot Features

Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Defence Therapeutics Inc (QB)

Defence Therapeutics Inc (QB) (DTCFF)

0,3017
-0,00055
(-0,18%)
Fermé 02 Juillet 10:00PM

Defence Therapeutics Inc (QB) (DTCFF) Opérations d'Initiés

-
Filtrer par:
Date Nom du détenteur Actions transigées Fourchette de valeur ($) Type d'opération Fourchette de prix ($) Actions en fin de déclaration % de variation
2026-06-03Dr. John BeaverDirector150,00k0,00Derivative Acquisition Under Employee Benefit Plan-150,00k-
2026-04-30Mr. Sebastien PlouffeFounder, CEO, President & Director200,00k0,00Derivative Exercise and Retained Stock-1,80M12,50%
2026-03-06Omar RifaiInitié5,00M2,02MAchat0,405,75M666,67%
2025-12-10Dr. Svetlana SelivanovaIndependent Director50,00k0,00Derivative Acquisition Under Employee Benefit Plan0,61150,00k50,00%
2025-12-10Dr. Amie PhinneyStrategy & Business Advisor and Independent Director50,00k0,00Derivative Acquisition Under Employee Benefit Plan0,61150,00k50,00%
2025-12-10Mr. Sebastien PlouffeFounder, CEO, President & Director800,00k0,00Derivative Acquisition Under Employee Benefit Plan0,59 - 0,611,40M133,33%
2025-12-10Philippe LefrancoisInitié50,00k0,00Derivative Acquisition Under Employee Benefit Plan0,61150,00k50,00%
2025-12-10Dr. Sarkis MeterissianMember of Scientific Advisory Board200,00k0,00Derivative Acquisition Under Employee Benefit Plan0,61450,00k80,00%
2025-12-10Mr. Sebastien PlouffeFounder, CEO, President & Director400,00k0,00Derivative Acquisition Under Employee Benefit Plan0,591,40M40,00%

Dernières Valeurs Consultées

Delayed Upgrade Clock